The Fibrinolytic Efficacy and Impact on Plasma von Willlebrand Factor of Losartan Compared with Atenolol in Essential Hypertensives / 中华高血压杂志
Chinese Journal of Hypertension
;
(12)2007.
Artículo
en Chino
| WPRIM
| ID: wpr-589320
ABSTRACT
Objectives To compare the effects of losartan and atenolol on fibrinolytic system and plasma von willebrand factor (vWF) in patients with essential hypertension. Methods Sixty patients with mild to moderate essential hypertension were randomized to receive lostartan(50 mg/d, n=30) or atenolol(50 mg/d, n=30) for 8 weeks. If the goal blood pressure(
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
Chinese Journal of Hypertension
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS